Garcia, R. et al. A Study of the Effects on Bacteremia and Sharps Injury Rates after Introduction of an Advanced Luer Activated Device (LAD) for Intravascular Access in a Large Hospital Setting.
This study tracked bloodstream infection rates and needlestick injuries after converting to the Flolink device. The Flolink and MaxPlus have identical specifications and geometry. They are the same product with the exception of color.
Download Pdf
Lange Victor, Tarwater Janice. Infection risk associated with a closed luer access device.
Submitted for publication
The purpose of this study was to ascertain whether a needleless connector, when microbiologically challenged, can be thereafter decontaminated with 70% IPA and maintain a physical barrier. Connectors were challenged for 3 consecutive days, 24 inoculations per day and 24 access per day, 8 of which per static insertions.
Download Pdf
Eight Day Microbial Challenge of the MaxPlus Positive Displacement Connector
The purpose of this study was to microbiologically challenge the MaxPlus valve over an extended 8 day period. The extended microbial challenge test results indicate that, in all cases, the MaxPlus continued to provide a physical barrier to contamination for an eight day period.
Download Pdf
Comparison of Contamination Rates among Needleless Access Devices in a Simulated Clinical Use - MaxPlus and ICU Clave®.
The MaxPlus and the ICU Medical Clave device were challenged to compare device susceptibility to contamination during multiple activations.
Download Pdf
The Use of MaxPlus to Assist in the Prevention and Reduction of BSI's: Results from Two Facilities
Infection Control Professionals from 2 major (500 beds, 523 beds) hospitals tracked CLBSI's before and after implementation of the MaxPlus valve to measure the effectiveness of implementing the MaxPlus as tool to assist in CLBSI prevention.
Download Pdf